MARKSANS PHARMA
Back to Income Statement
|
MARKSANS PHARMA Last 5 Year Profit After Tax History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Profit After Tax | ₹187 Cr | ₹239 Cr | ₹120,752,685 Cr | ₹80 Cr | ₹36 Cr |
What is the latest Profit After Tax of MARKSANS PHARMA ?
Year | Profit After Tax |
---|---|
Mar2023 | ₹187 Cr |
Mar2022 | ₹239 Cr |
Mar2021 | ₹120,752,685 Cr |
Mar2020 | ₹80 Cr |
Mar2019 | ₹36 Cr |
How is Profit After Tax of MARKSANS PHARMA Trending?
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2023 | ₹187 Cr | -21.68 | |
Mar2022 | ₹239 Cr | -100.00 | |
Mar2021 | ₹120,752,685 Cr | 150,120,720.89 | |
Mar2020 | ₹80 Cr | 124.68 | |
Mar2019 | ₹36 Cr | - |
Compare Profit After Tax of peers of MARKSANS PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MARKSANS PHARMA | ₹7,514.1 Cr | -1.2% | 9.9% | 106.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹360,452.0 Cr | 1.1% | -6.6% | 56.7% | Stock Analytics | |
CIPLA | ₹113,132.0 Cr | 0.2% | -4.4% | 54.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹106,191.0 Cr | 4.8% | 18.9% | 23.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,512.0 Cr | 4.3% | 2.6% | 29.9% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,954.5 Cr | 2.2% | -4.6% | 86.6% | Stock Analytics |
MARKSANS PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MARKSANS PHARMA | -1.2% |
9.9% |
106.4% |
SENSEX | 1% |
2.8% |
23.9% |
You may also like the below Video Courses